Avivagen Inc (VIV):企業の財務・戦略的SWOT分析

◆英語タイトル:Avivagen Inc (VIV) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH186117FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Avivagen Inc (Avivagen), is a biotechnology company that provides drug development and animal healthcare products. It offers OxC-beta an active ingredient used to support the innate immune system and a healthy inflammatory condition of living beings. Avivagen’s oxidized carotenoids promote and support healthy joint function, enhance healthy condition of skin and coat and maintain normal intestinal function. The company also develops supplements such as OxC-beta Livestock premix and Vivamune Health Chews for companion animals. Avivagen is headquartered in Ottawa, Canada.

Avivagen Inc Key Recent Developments

Jan 31,2021: Avivagen Inc. Announces Results for the First Quarter Ending January 31, 2021
Dec 16,2020: Avivagen announces results for fiscal year ending October 31, 2020
Oct 31,2020: Ottawa, ON /Business Wire/ December 16, 2020 / — Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Company”) today reported its audited financial results for the fiscal year ended October 31, 2020. Unless otherwise noted, all figures are in Canadi

This comprehensive SWOT profile of Avivagen Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Avivagen Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Avivagen Inc – Key Information
Avivagen Inc – Overview
Avivagen Inc – Key Employees
Avivagen Inc – Key Employee Biographies
Avivagen Inc – Key Operational Heads
Avivagen Inc – Major Products and Services
Avivagen Inc – History
Avivagen Inc – Company Statement
Avivagen Inc – Locations And Subsidiaries
Avivagen Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Avivagen Inc – Business Description
Avivagen Inc – Corporate Strategy
Avivagen Inc – SWOT Analysis
SWOT Analysis – Overview
Avivagen Inc – Strengths
Avivagen Inc – Weaknesses
Avivagen Inc – Opportunities
Avivagen Inc – Threats
Avivagen Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Avivagen Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Avivagen Inc, Key Information
Avivagen Inc, Key Ratios
Avivagen Inc, Share Data
Avivagen Inc, Major Products and Services
Avivagen Inc, History
Avivagen Inc, Key Employees
Avivagen Inc, Key Employee Biographies
Avivagen Inc, Key Operational Heads
Avivagen Inc, Other Locations
Avivagen Inc, Subsidiaries
Avivagen Inc, Key Competitors
Avivagen Inc, SWOT Analysis
Avivagen Inc, Ratios based on current share price
Avivagen Inc, Annual Ratios
Avivagen Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Avivagen Inc (VIV):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Meggitt Training Systems, Inc.:企業の戦略・SWOT・財務情報
    Meggitt Training Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Meggitt Training Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Bina Puri Holdings Bhd:企業の戦略・SWOT・財務情報
    Bina Puri Holdings Bhd - Strategy, SWOT and Corporate Finance Report Summary Bina Puri Holdings Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Mitsubishi International Food Ingredients, Inc.:戦略・SWOT・企業財務分析
    Mitsubishi International Food Ingredients, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi International Food Ingredients, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • AJ Lucas Group Ltd (AJL):企業の財務・戦略的SWOT分析
    AJ Lucas Group Ltd (AJL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • GKE Corporation Limited (595):企業の財務・戦略的SWOT分析
    GKE Corporation Limited (595) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • MicuRx Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary MicuRx Pharmaceuticals Inc (MicuRx) is a developer of antibiotics for drug-resistant bacterial infections. The company develops a pipeline of antimicrobial agents using its proprietary drug discovery platform to treat both gram-positive and gram-negative bacterial infections. Its lead produc …
  • Basilea Pharmaceutica Ltd (BSLN):企業の財務・戦略的SWOT分析
    Summary Basilea Pharmaceutica Ltd (Basilea) is a biopharmaceutical company that develops and markets antibiotics, antifungals and oncology drugs. The company’s products address increasing resistance and non-response to present treatment options for various therapeutic areas such as cancer, bacterial …
  • Legal & General Group Plc:戦略・SWOT・企業財務分析
    Legal & General Group Plc - Strategy, SWOT and Corporate Finance Report Summary Legal & General Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Mmi Holdings Ltd.
    Mmi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mmi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Alimera Sciences Inc (ALIM):製薬・医療:M&Aディール及び事業提携情報
    Summary Alimera Sciences Inc (Alimera) is a biopharmaceutical company that researches, develops and commercializes prescription ophthalmic pharmaceuticals. The company’s products include Iluvien, an intravitreal implant of fluocinolone acetonide which is indicated for the treatment of chronic diabet …
  • Credicorp Ltd (BAP):企業の財務・戦略的SWOT分析
    Credicorp Ltd (BAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Precision Therapeutics Inc (AIPT):医療機器:M&Aディール及び事業提携情報
    Summary Precision Therapeutics Inc (Precision Therapeutics), a joint venture between Skyline Medical and Helomics, is a medical device company. The company’s business divisions include artificial intelligence to personalized medicine and drug discovery; and system for automated, direct-to-drain medi …
  • Tech Mahindra Limited (TECHM):企業の財務・戦略的SWOT分析
    Tech Mahindra Limited (TECHM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • SK Holdings Co Ltd (034730):企業の財務・戦略的SWOT分析
    SK Holdings Co Ltd (034730) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • M.D.C. Holdings Inc:戦略・SWOT・企業財務分析
    M.D.C. Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary M.D.C. Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cohu, Inc. (COHU):企業の財務・戦略的SWOT分析
    Cohu, Inc. (COHU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Celsion Corp (CLSN)-製薬・医療分野:企業M&A・提携分析
    Summary Celsion Corp (Celsion) is an oncology company that focuses on developing a portfolio of new cancer treatments, including directed chemotherapies, RNA based therapies and DNA-mediated immunotherapy. The company’s three platform technologies including Lysolipid Thermally Sensitive Liposomes (L …
  • Glenmark Pharmaceuticals Ltd (GLENMARK):企業の財務・戦略的SWOT分析
    Glenmark Pharmaceuticals Ltd (GLENMARK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Barnwell Industries Inc (BRN):石油・ガス:M&Aディール及び事業提携情報
    Summary Barnwell Industries Inc (Barnwell) is a diversified company. The company's business activities include oil and natural gas, land investment, and contract drilling. Its oil and natural gas division offers exploration, development, production, and sales of oil and natural gas in Canada. Barnwe …
  • Abbott Laboratories (ABT):医療機器:M&Aディール及び事業提携情報
    Summary Abbott Laboratories (Abbott) develops, manufactures, and sells a diversified range of healthcare products including drugs, diagnostics, branded generics, and vascular and nutritional products. The company’s products comprise specialized medicines; medical diagnostic instruments and tests; mi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆